Breaking News

Cirrus to Invest in cGMP Manufacturing Suite in US

Now able to extend offerings in the U.S. from contract development to manufacturing.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cirrus Pharmaceuticals, a Kemwell company, which is a 100% services oriented company providing pharmaceutical contract development and manufacturing services, will be investing in a flexible cGMP suite in its facility in North Carolina’s Research Triangle Park. “With this investment, we are bringing our customers a new service from our U.S. facility,” said Ninad Deshpanday, president of R&D at Kemwell. “We will offer our clients cGMP manufacturing services for many dosage ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters